Healthpeak Properties, Inc. (DOC)
(Real Time Quote from BATS)
$18.82 USD
+0.48 (2.62%)
Updated Apr 26, 2024 10:18 AM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Income Statements
Fiscal Year end for Healthpeak Properties, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,181 | 2,061 | 1,896 | 1,645 | 1,997 |
Cost Of Goods | 902 | 863 | 773 | 783 | 879 |
Gross Profit | 1,279 | 1,198 | 1,123 | 862 | 1,118 |
Selling & Adminstrative & Depr. & Amort Expenses | 857 | 853 | 808 | 708 | 988 |
Income After Depreciation & Amortization | 422 | 345 | 315 | 154 | 130 |
Non-Operating Income | 93 | 335 | -29 | 282 | 147 |
Interest Expense | 200 | 173 | 158 | 218 | 226 |
Pretax Income | 315 | 507 | 128 | 218 | 51 |
Income Taxes | -10 | -4 | -3 | -9 | -17 |
Minority Interest | 29 | 16 | 20 | 15 | 15 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 10 | 2 | 6 | -67 | -9 |
Income From Cont. Operations | 335 | 514 | 138 | 161 | 60 |
Extras & Discontinued Operations | 0 | 3 | 388 | 268 | 0 |
Net Income (GAAP) | 306 | 500 | 506 | 414 | 46 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,075 | 963 | 933 | 797 | 819 |
Depreciation & Amortization (Cash Flow) | 653 | 619 | 617 | 643 | 689 |
Income After Depreciation & Amortization | 422 | 345 | 315 | 154 | 130 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 547.28 | 539.15 | 539.24 | 531.06 | 489.34 |
Diluted EPS Before Non-Recurring Items | 0.56 | 0.92 | 0.22 | 0.61 | 0.09 |
Diluted Net EPS (GAAP) | 0.56 | 0.92 | 0.93 | 0.77 | 0.09 |
Fiscal Year end for Healthpeak Properties, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 553.65 | 556.24 | 545.43 | 525.68 |
Cost Of Goods | NA | 224.40 | 232.73 | 221.84 | 223.09 |
Gross Profit | NA | 329.25 | 323.51 | 323.59 | 302.59 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 219.07 | 207.14 | 226.75 | 203.99 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 110.18 | 116.37 | 96.84 | 98.60 |
Non-Operating Income | NA | 2.60 | 1.48 | 6.84 | 82.35 |
Interest Expense | NA | 52.78 | 50.51 | 49.07 | 47.96 |
Pretax Income | NA | 60.00 | 67.34 | 54.61 | 132.99 |
Income Taxes | NA | -11.84 | 0.79 | 1.14 | 0.30 |
Minority Interest | NA | 4.45 | 4.44 | 4.30 | 15.56 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 3.56 | 2.10 | 2.73 | 1.82 |
Income From Cont. Operations | NA | 75.39 | 68.66 | 56.20 | 134.51 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 70.94 | 64.21 | 51.90 | 118.95 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 547.36 | 547.33 | 547.29 | 547.11 |
Diluted EPS Before Non-Recurring Items | NA | 0.13 | 0.12 | 0.09 | 0.22 |
Diluted Net EPS (GAAP) | NA | 0.13 | 0.12 | 0.09 | 0.22 |